Company Overview of BioRelix, Inc.
BioRelix, Inc., a biopharmaceutical company, engages in the discovery and development of anti-biotic drug candidates for the treatment of infectious diseases in the United States. It develops a portfolio of riboswitch-based therapeutic agents to overcome the lethal and devastating causes of bacterial infections. The company was founded in 2005 and is based in New Haven, Connecticut.
5 Science Park at Yale
401 Winchester Avenue
New Haven, CT 06511
Founded in 2005
Key Executives for BioRelix, Inc.
Similar Private Companies By Industry
|Biosynthema, Inc.||United States|
|MBC Pharma, Inc.||United States|
|Adynxx, Inc||United States|
|Manhattan Drug Company, Inc.||United States|
|Vallinex Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact BioRelix, Inc., please visit www.biorelix.com. Company data is provided by Capital IQ. Please use this form to report any data issues.